This analysis revealed that while some mutants had significant defects in bulk translation and particular biochemical properties, the most common and well-correlated defects in medulloblastoma-associated mutants of DDX3X/DED1 were in specific translation processes, suggesting that these should be a focus in future studies of DDX3X-driven oncogenesis. This evidence concerns the gene DDX3X and medulloblastoma.